Home
Conditions
Demyelinating Diseases

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,931 public trials 462 recruiting studies

Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)

NCT00395200

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +8 more
Locations: University of Cambridge Dept of Clinical Neurosciences Cambridge, Cambridgeshire, United Kingdom

University College London Institute of Neurology London, United Kingdom

View Trial Details

Completed

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).

NCT00337779

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Not specified

View Trial Details

Completed

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

NCT01448252

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Dept of Neurology,Hadassah ein-Kerem Jerusalem, Israel

View Trial Details

Completed

Safety and Tolerability of Rituximab in Neuromyelitis Optica

NCT00501748

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +21 more
Locations: UCSF MS Center , 350 Parnassus Ave , suite #908 San Francisco, California, United States

The Neurological Institute of New York MS Center Columbia University Medical Center 710 West 168th Street,, New York, United States

View Trial Details

Completed

Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

NCT01432704

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b

NCT01111656

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations: Department of Neurology, Bern University Hospital, and University of Bern Bern, Canton of Bern, Switzerland

View Trial Details

Completed

Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study

NCT00937677

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Jacobs Neurological Institute Buffalo, New York, United States

View Trial Details

Completed

Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis

NCT00785473

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bone Diseases, +11 more
Locations: University Hospital of North Norway Tromsø, Norway

View Trial Details

Completed

Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS)

NCT01097538

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +13 more
Locations: Centre for Health Promotion and Rehabilitation, McMaster University Hamilton, Ontario, Canada

View Trial Details

Completed

Health Behavior Change in Chronic Disease Management

NCT00118547

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: VA Puget Sound Health Care System, Seattle Seattle, Washington, United States

View Trial Details

Demyelinating Diseases

Demyelinating Diseases trial results

Related conditions